Loading...
Fetching results...
0 items found

A0762: Propensity matched comparison of radical cystectomy with trimodality therapy for muscle invasive bladder cancer (MIBC): A multi-institutional study

Speaker
Prof. A.R. (Alexandre R.) Zlotta
Authors
Zlotta A.R.1, Ballas L.K.2, Niemierko A.3, Lajkosz K.4, Kuk C.1, Miranda G.2, Drumm M.3, Mari A.5, Thio E.2, Fleshner N.E.6, Kulkarni G.S.6, Chung P.7, Bristow R.8, Berlin A.7, Sridhar S.9, Feldman A.S.10, Wszolek M.10, Lee R.11, Zietman A.3, Shipley W.3, Saylor P.11, Daneshmand S.12, Efstathiou J.A.3
Institutions
1Sinai Health System, Dept. of Surgery, Dept. of Urology, Toronto, Canada, 2University of Southern California, Dept. of Radiation Oncology, Los Angeles, United States of America, 3Massachusetts General Hospital, Dept. of Radiation Oncology, Boston, United States of America, 4University Health Network, Dept. of Biostatistics, Toronto, Canada, 5University of Florence, Dept. of Urology, Florence, Italy, 6University Health Network, Dept. of Surgical Oncology, Dept. of Urology, Toronto, Canada, 7University Health Network, Dept. of Radiation Oncology, Toronto, Canada, 8University of Manchester, Dept. of Cancer Sciences, Manchester, United Kingdom, 9University Health Network, Dept. of Medical Oncology, Toronto, Canada, 10Massachusetts General Hospital, Dept. of Urology, Boston, United States of America, 11Massachusetts General Hospital, Dept. of Medical Oncology, Boston, United States of America, 12University of Southern California, Dept. of Urology, Los Angeles, United States of America
Event
37th Annual EAU Congress
Date – Time - Location
03 July 2022, 14:00 - 15:30, Yellow Area, Room Forum
Session
Abstract Session 41 - Bladder cancer radical therapy, surgery and QOL impact
Topic
Urothelial Cancer, MIBC - Treatment, Radiotherapy/Brachytherapy
  • © 2022 European Association of Urology
  • Disclaimer